Immuno-oncology companies
Companies whose enriched business profile is tagged “Immuno-oncology”, drawn from their SEC filings + website text. Sorted by market capitalization; every figure is delayed data from SEC EDGAR + market data, shown with its as-of date.
- Exelixis (EXEL) Health Care — Exelixis is a profitable oncology company commercializing the multi-kinase inhibitor cabozantinib across multiple cancer indications while advancing a pipeline of next-generation small molecules and antibody-drug conjugates. ask →
- NEKTAR THERAPEUTICS (NKTR) Health Care — A clinical-stage biotechnology company developing next-generation immunomodulatory therapies for autoimmune diseases and cancer. ask →
- JANUX THERAPEUTICS INC (JANX) Health Care — Janux Therapeutics is a clinical-stage biotech developing next-generation, tumor-activated bispecific immunotherapies to improve the safety and efficacy of cancer and autoimmune treatments. ask →
- CANDEL THERAPEUTICS INC (CADL) Health Care — Clinical-stage biopharmaceutical company developing off-the-shelf viral immunotherapies to trigger systemic anti-tumor immune responses by inducing immunogenic cell death within solid tumors. ask →
- CRESCENT BIOPHARMA INC (CBIO) Health Care — A clinical-stage oncology biotech developing a PD-1 x VEGF bispecific antibody backbone and a portfolio of antibody-drug conjugates to treat solid tumors. ask →
- ALX ONCOLOGY HOLDINGS INC (ALXO) Health Care — An early-stage immuno-oncology biotech advancing a next-generation CD47 blocker designed to restore macrophage tumor-killing when combined with targeted cancer therapies. ask →
- Pyxis Oncology, Inc. (PYXS) Health Care — Pyxis Oncology is a clinical-stage biopharma developing innovative antibody-drug conjugates (ADCs) that target the tumor microenvironment to improve efficacy in difficult-to-treat solid tumors. ask →
- Indaptus Therapeutics, Inc. (INDP) Health Care — A clinical-stage biotechnology company currently evaluating strategic options and potential business combinations to maximize shareholder value. ask →
Not quite it? Describe exactly what you want →
Frequently asked
What are the largest immuno-oncology companies?
By market capitalization, the largest immuno-oncology companies in the catalog include Exelixis (EXEL), NEKTAR THERAPEUTICS (NKTR), JANUX THERAPEUTICS INC (JANX), CANDEL THERAPEUTICS INC (CADL), CRESCENT BIOPHARMA INC (CBIO).
How many immuno-oncology companies does stocks-llm track?
stocks-llm currently lists 8 immuno-oncology companies (as of 2026-08-03), each with dated fundamentals from SEC EDGAR and market data. Informational only — not financial advice.
Data: SEC EDGAR (filings) + market data (fundamentals, delayed daily-close). Figures shown with their as-of date.
Last updated 2026-08-03.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.